09-13, 10:45–11:15 (Europe/Istanbul), Laryngology 1
Background
Subglottic stenosis (SGS) of uncertain aetiology including idiopathic SGS (iSGS) and vasculitis-associated SGS (vSGS, classically granulomatosis with polyangiitis)—remains a therapeutic challenge. Restenosis commonly follows office based interventions, operating room (OR) procedures, and open neck surgery, yet definitive treatment guidelines are still lacking.
Objective
Compare long-term outcomes of office based, OR treatment and open neck procedures in uncertain-etiology SGS and use those data to craft a pragmatic flow chart that standardises work-up, treatment decision making.
Description
A retrospective institutional cohort of patients with idiopathic or vasculitic subglottic stenosis (SGS) will be analysed. Outcomes will include decannulation rate, number of operative and office-based interventions, complication rate and management.
Outcomes
Among 200 patients undergoing CTR, 15 had idiopathic SGS (all female) and 5 vasculitis SGS with a 100% decannulation rate. Postoperative issues included granulomas (n=6) managed with oral corticosteroids in 3 cases, and additional interventions—radial incision with intralesional corticosteroids, SILSI in others), and 1 case of restenosis managed with radial incision and keel placement. In the endoscopic group (N=24), 19 had iSGS (18 female, 1 male) and 2 vSGS (all female) undergoing a total of 33 OR procedures (including radial incisions, balloon dilatation, steroid injection, and synechia lysis. Three patients received T-tube placement and one required keel) and 5 office-based steroid injections (SILSI). Based on these findings, we will propose a structured, evidence-informed flow chart to guide clinical decision-making in the management of SGS.
Purpose of your Proposal:
Subglottic stenosis (SGS) of uncertain aetiology including idiopathic SGS and vasculitis-associated SGS remains a therapeutic challenge. Both, share a propensity for restenosis after airway expansion, yet no consensus management algorithm exists. Therefore, based on our findings we propose a structured flow chart streamlining decision making SGS treatment.
I graduated as a medical doctor from the University Our Lady Of Good Counsel, Tirana, Albania, in July 2023. My journey in the field of medicine has been characterized by a series of experiences and internships, particularly in the Head and Neck specialty, commencing with a two-year tenure at the American Hospital in Tirana.
My enriching experiences continued with three weeks spent at Policlinico Tor Vergata, Rome, in May 2022, followed by an equally enlightening period of three weeks at Ospedale Civile, Brescia.
I obtained my medical license from Policlinico Tor Vergata, Rome, between October and December 2023. During this period, I completed a two-month internship at the ENT department of Istituto Nazionale Tumori Regina Elena (IFO).
I am currently a resident in Head and Neck Surgery in Genoa, where I continue to deepen my clinical expertise.
Furthermore, I've actively contributed to the academic sphere by co-authoring abstracts and articles selected for publication and presentation at conferences held in Greece and Rome, reflecting my dedication to continuous learning and sharing insights with the international medical community.